2023
DOI: 10.53933/sspmpm.v3i4.114
|View full text |Cite
|
Sign up to set email alerts
|

Management and Marketing of Circulation of First-Line Antituberculosis Medicines: Use of Innovative Research Technologies

Alina Osyntseva,
Valentyn Shapovalov

Abstract: The management and marketing of first-line antituberculosis medicines are paramount for the effective containment and treatment of tuberculosis, a global health challenge. Ensuring the optimal circulation of these medicines requires a seamless integration of supply chain management, demand forecasting, and strategic marketing. The introduction of innovative research technologies has transformed the landscape, offering enhanced methods for drug distribution, patient adherence, and efficacy tracking. Digital pla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Pharmacotherapy of tuberculosis consists of an intensive phase and a continuation phase. The appearance of multidrug-resistant tuberculosis requires at least 20 months of pharmacotherapy with second-line drugs, more toxic and less effective (capreomycin, kanamycin, amikacin, and fluoroquinolones) [19].…”
mentioning
confidence: 99%
“…Pharmacotherapy of tuberculosis consists of an intensive phase and a continuation phase. The appearance of multidrug-resistant tuberculosis requires at least 20 months of pharmacotherapy with second-line drugs, more toxic and less effective (capreomycin, kanamycin, amikacin, and fluoroquinolones) [19].…”
mentioning
confidence: 99%